David Rutledge, PharmD

Original Contribution

Clinical Outcomes in the Percutaneous Coronary Intervention of In-Stent Restenosis With Everolimus-Eluting Stents

09/06/2014

Kyung Woo Park , MD;

David Rutledge , PharmD;

Moo-Hyun Kim , MD, PhD;

Mitchell W. Krucoff , MD;

Ehtisham Mahmud , MD;

Hyo-Soo Kim , MD, PhD;

Michael S. Lee , MD, DPM, FACFAS, FACC, FSCAI;

James B. Hermiller , MD, FACC, FSCAI;

Tae Yang , MD;

George D. Dangas , MD, PhD;

Xience V USA is a prospective multicenter registry evaluating outcomes in patients treated with EES. Here, we present the 12-month clinical outcomes in patients who received EES for the treatment of in-stent restenosis (ISR) and non-ISR.

Xience V USA is a prospective...

09/06/2014

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

David Rutledge, PharmD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products